By Counterforce Health Team in Evrysdi (risdiplam) —

How to Get Evrysdi (Risdiplam) Covered by Aetna CVS Health in Georgia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Evrysdi Covered by Aetna CVS Health in Georgia

Evrysdi (risdiplam) is covered by Aetna CVS Health in Georgia but requires prior authorization for all plan types. Your fastest path to approval: (1) Have your neurologist submit genetic testing results showing biallelic SMN1 mutations, (2) Include baseline motor function scores and step therapy documentation via Aetna's specialty portal, (3) Request expedited review if medically urgent. Start today: Call the number on your insurance card to verify your plan type and begin the PA process through CVS Specialty Pharmacy coordination.

Table of Contents

  1. Plan Types & Network Requirements
  2. Formulary Status & Coverage Details
  3. Prior Authorization Requirements
  4. Specialty Pharmacy Process
  5. Cost-Sharing Basics
  6. Submission Process & Forms
  7. Common Approval Patterns
  8. Appeals Process in Georgia
  9. FAQ

Plan Types & Network Requirements

HMO vs. PPO vs. EPO Differences

If you have an Aetna HMO plan in Georgia, you'll need a referral from your primary care physician (PCP) to see a neurologist for SMA treatment. The referral is valid for 90 days initially and up to one year total. Your PCP must submit this electronically through Aetna's provider portal.

PPO and EPO members can see neurologists directly without referrals, though staying in-network keeps costs lower. EPO plans require you to use only in-network providers (except emergencies), while PPO plans allow out-of-network care at higher cost.

Note: The referral doesn't replace the need for prior authorization—Evrysdi still requires separate PA approval regardless of your plan type.

Network Restrictions for SMA Care

All Aetna plans in Georgia require you to use participating neurologists and specialty pharmacies. Search Aetna's provider directory online or call member services to find SMA specialists in your area. CVS Specialty Pharmacy handles Evrysdi fulfillment exclusively—it cannot be filled at retail pharmacies.

Formulary Status & Coverage Details

Coverage Across Plan Types

Evrysdi appears on Aetna's 2024 formularies including:

  • Advanced Control Plans
  • Standard Opt Out Plans
  • Exchange/ACA marketplace plans
  • Medicare Advantage plans
  • Medicaid managed care plans

Formulary tier: Specialty Tier 4 or 5, typically requiring 20-40% coinsurance for commercial plans. Medicare Part D follows different cost-sharing rules based on coverage phases.

Alternative Medications

Aetna also covers other SMA treatments that may require step therapy documentation:

  • Spinraza (nusinersen) - intrathecal injection every 4 months
  • Zolgensma (onasemnogene) - one-time gene therapy (age restrictions apply)

Prior Authorization Requirements

Essential Documentation Checklist

Requirement Details Where to Find
Genetic Testing Biallelic SMN1 mutations confirmed Lab report from genetics testing
SMA Diagnosis Type 1, 2, 3, 4, or unknown with ICD-10 codes Neurologist assessment
Specialist Prescription From neurologist or SMA expert Provider credentials verification
Motor Function Scores CHOP-INTEND, HFMSE, RULM, or similar Recent assessment (<1 month)
Step Therapy Evidence Prior trial/failure of Spinraza/Zolgensma OR contraindication rationale Treatment history documentation
Dosing Verification Weight-based dosing per FDA label Current weight, BSA calculations

Medical Necessity Criteria

Aetna's Clinical Policy Bulletin 4074-A requires documentation of:

  • Confirmed 5q-autosomal recessive SMA diagnosis
  • No invasive ventilator dependence (tracheostomy)
  • No concurrent use with other SMN-modifying therapies
  • Appropriate candidate for oral medication administration

Patients requiring non-invasive ventilation only during sleep/naps remain eligible for coverage.

Specialty Pharmacy Process

CVS Specialty Coordination Steps

  1. Prescription Submission: Your neurologist sends the prescription directly to CVS Specialty Pharmacy
  2. Insurance Verification: CVS verifies your Aetna benefits and initiates PA if needed
  3. Patient Enrollment: CVS calls you to confirm delivery details and provide administration supplies
  4. Medication Preparation: CVS prepares the oral solution (powder mixed with water) with 64-day expiration
  5. Home Delivery: 30-day supply ships within 2-3 business days of PA approval

Key Contact: MySMA Support at 833-EVRYSDI (833-387-9734) provides enrollment assistance and benefits verification.

Administration Requirements

Evrysdi requires specific preparation and administration:

  • Take immediately after preparation (discard if >5 minutes in oral syringe)
  • Missed dose: Take if <6 hours late; skip if longer
  • No make-up dose if vomited within 30 minutes

Cost-Sharing Basics

Typical Patient Costs

Commercial plans: 20-40% coinsurance after deductible (specialty tier) Medicare Advantage: Varies by plan; often $47-100+ monthly copay Medicaid managed care: Usually $0-3 copay with prior authorization

Annual list price: Up to $340,000 based on weight-based dosing, though patient out-of-pocket costs are typically much lower due to insurance coverage and manufacturer support programs.

Financial Assistance Options

  • Genentech Patient Foundation: Need-based assistance for eligible patients
  • Cure SMA: Patient navigation and support resources
  • Georgia 211: State assistance program information (dial 2-1-1)

Submission Process & Forms

Electronic Submission (Fastest)

Primary method: Aetna specialty PA portal or Availity electronic system

  • Upload all required documents in single submission
  • Possible auto-approval within 24 hours for complete applications
  • Track status through provider portal

Paper/Fax Alternative

Use Aetna's Evrysdi Precertification Request Form if electronic submission unavailable.

Critical form sections:

  • Section G (Clinical Information): Complete all SMA type, genetics, and motor function fields
  • Prior therapy documentation: Specify Zolgensma/Spinraza trial results or contraindications
  • Prescriber attestation: Confirm SMA specialist credentials

Timeline Expectations

Review Type Timeline When to Use
Standard PA 15-30 days Stable patients, planned treatment
Expedited Review 72 hours Life-threatening progression, hospital discharge
Reauthorization 30 days before expiration Annual renewals (initiate early)

Expedited requests: Call 1-866-814-5506 with medical urgency documentation.

Common Approval Patterns

Strongest Submissions Include

Complete genetic documentation: Lab report clearly showing biallelic SMN1 mutations (not just "SMA positive")

Detailed motor assessments: Recent scores with improvement goals and monitoring plan

Step therapy rationale: Either documented trial/failure of alternatives OR clear contraindication explanation citing medical literature

Specialist involvement: Prescription from neurologist with SMA expertise, not general pediatrician

Clinician Corner: Medical necessity letters should reference FDA labeling, cite relevant SMA treatment guidelines, and specify treatment goals with measurable outcomes. Include baseline motor function scores and monitoring schedule.

Common Denial Reasons & Solutions

Denial Reason How to Fix
Missing genetic testing Submit lab report showing SMN1 mutations
Incomplete motor assessment Provide recent CHOP-INTEND, HFMSE, or RULM scores
Step therapy not met Document Spinraza/Zolgensma trial or contraindication
Non-specialist prescriber Transfer prescription to neurologist
Dosing concerns Verify weight-based calculation per FDA label

Appeals Process in Georgia

Internal Appeal Timeline

Deadline: 180 days from denial date Decision timeframe: 30 days for standard appeals, 72 hours for expedited

Required documentation:

  • Copy of denial notice
  • Medical records supporting necessity
  • Physician letter addressing specific denial reasons
  • Failed therapy documentation (if step therapy issue)

Filing Methods

  1. Aetna member portal (fastest)
  2. Phone: Number on insurance card
  3. Written appeal: Include Member Complaint and Appeal Form (optional)

Georgia External Review Rights

If Aetna denies your internal appeal, Georgia law provides independent external review:

Deadline: 60 days from final internal denial Cost: Free to consumers
Timeline: 30 business days (expedited: 72 hours for urgent cases) Contact: Georgia Department of Insurance at 1-800-656-2298

Georgia's external review is binding on Aetna—if approved, they must cover the treatment.

Important: Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Their platform helps patients and clinicians draft point-by-point rebuttals aligned to Aetna's specific policy requirements, pulling the right medical citations and clinical evidence to strengthen your case.

Consumer Support Resources

  • Georgia Department of Insurance Consumer Services: 1-800-656-2298
  • Georgians for a Healthy Future: Consumer assistance and appeal guidance
  • Georgia Legal Services Program: For Medicaid/PeachCare appeals

FAQ

How long does Aetna prior authorization take for Evrysdi in Georgia? Standard review takes 15-30 days. Expedited review (for urgent medical needs) takes up to 72 hours. Submit complete documentation to avoid delays.

What if Evrysdi is non-formulary on my specific plan? Request a formulary exception with medical necessity documentation. Aetna must review non-formulary requests with clinical justification.

Can I request expedited appeal if my child's condition is worsening? Yes. Document medical urgency showing how delays could seriously jeopardize health. Your neurologist can call 1-866-814-5506 for expedited processing.

Does step therapy apply if we tried Spinraza outside Georgia? Previous treatment history from any state counts toward step therapy requirements. Provide documentation of prior trials, responses, and reasons for switching.

What motor function tests does Aetna accept? CHOP-INTEND (infants), Hammersmith Functional Motor Scale, RULM, MFM32, or BSID-III. Tests should be recent (within 1 month for continuing treatment).

How do I find an in-network SMA specialist in Georgia? Use Aetna's online provider directory or call member services. Search for pediatric neurologists or neuromuscular specialists with SMA experience.

What happens if CVS Specialty can't fill my prescription? CVS Specialty is the exclusive pharmacy for Evrysdi under Aetna plans. If there are issues, contact MySMA Support at 833-EVRYSDI for resolution assistance.

Can I appeal to Georgia if I have a Medicare Advantage plan? Medicare Advantage appeals follow federal Medicare rules first, then may have additional state protections. Start with Medicare's appeal process, then consult Georgia DOI if needed.

When to Escalate

Contact the Georgia Department of Insurance if:

  • Aetna fails to respond within required timeframes
  • You believe the denial violates Georgia insurance laws
  • You need help filing an external review request

File a complaint: Use the online Insurance Complaint/Inquiry form or call 1-800-656-2298.

For patients navigating complex denials, Counterforce Health provides specialized expertise in crafting appeals that address Aetna's specific policy requirements, helping transform denial letters into successful coverage approvals through targeted medical evidence and regulatory compliance.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies and appeal processes may change. Always verify current requirements with Aetna directly and consult your healthcare provider for medical decisions. For the most up-to-date Georgia insurance regulations, contact the Georgia Department of Insurance.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.